Assessment of National Coverage and Out-of-Pocket Costs for Sacubitril/Valsartan under Medicare Part D

Colette Dejong, Dhruv S. Kazi, R. Adams Dudley, Randi Chen, Chien Wen Tseng

Research output: Contribution to journalLetterpeer-review

10 Scopus citations
Original languageEnglish (US)
Pages (from-to)828-830
Number of pages3
JournalJAMA cardiology
Volume4
Issue number8
DOIs
StatePublished - Aug 2019
Externally publishedYes

Bibliographical note

Funding Information:
Conflict of Interest Disclosures: Dr Fonarow reports research funding from the National Institutes of Health and personal fees from Abbott, Amgen, Bayer, Janssen, Medtronic, and Novartis, outside the submitted work. Dr Navar reports grants and personal fees from Amarin, Amgen, Regeneron, and Sanofi; personal fees from Novo Nordisk and AstraZeneca; and grants from Janssen, outside the submitted work. Dr Yancy reports spousal employment with Abbott Inc. No other disclosures were reported.

Cite this